These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12608153)
1. Interview: role of managed care in implementing NCEP-ATP III guidelines. Carver JC Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():7. PubMed ID: 12608153 [No Abstract] [Full Text] [Related]
3. Guidelines target many women for statins. Harv Womens Health Watch; 2002 Apr; 9(8):1-2. PubMed ID: 11959535 [No Abstract] [Full Text] [Related]
4. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins. Tran YB; Frial T; Miller PS Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788 [TBL] [Abstract][Full Text] [Related]
5. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline]. Lubsen J Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438 [No Abstract] [Full Text] [Related]
6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
7. [Statins in primary prevention - a must for the general practitioner?]. Zoller M Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299 [No Abstract] [Full Text] [Related]
8. Cost-efficacy analysis of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors based on results of the STELLAR trial: clinical implications for therapeutic selection. Chong PH; Varner D Pharmacotherapy; 2005 Feb; 25(2):270-8. PubMed ID: 15767241 [TBL] [Abstract][Full Text] [Related]
9. Improving compliance through health care system and pharmaceutical company partnerships. Kozma CM Manag Care Interface; 2003 Mar; 16(3):29-30. PubMed ID: 12715409 [No Abstract] [Full Text] [Related]
11. Stricter cholesterol guidelines broaden indications for the 'statin' drugs. Capriotti T Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600 [No Abstract] [Full Text] [Related]
12. The paradigm of stains: will the lower cost of generics translate into health gains? Seabra-Gomes R Rev Port Cardiol; 2007 May; 26(5):497-501. PubMed ID: 17691276 [No Abstract] [Full Text] [Related]
13. Intermittent claudication: a plea for guidelines for medical management. Powell JT Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850 [No Abstract] [Full Text] [Related]
14. Cost and effectiveness of cardiovascular prevention. Boyar A Am J Cardiol; 2007 Nov; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815 [No Abstract] [Full Text] [Related]
15. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands. Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351 [TBL] [Abstract][Full Text] [Related]
17. Standards of medical care in diabetes--2006: response to the American Diabetes Association. Tseng KH Diabetes Care; 2006 Nov; 29(11):2563-4; author reply 2564-5. PubMed ID: 17065711 [No Abstract] [Full Text] [Related]
18. A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines. Kelly SC; Gonzalo R; Petrasko M S D Med; 2014 Aug; 67(8):320-3. PubMed ID: 25163226 [No Abstract] [Full Text] [Related]
19. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]